Xometry Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
02-25
Xometry Inc reports results for the quarter ended December 31 - Earnings Summary
  • Xometry Inc XMTR.OQ reported quarterly adjusted earnings of 6 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -1 cents. The mean expectation of ten analysts for the quarter was for earnings of 3 cents per share. Wall Street expected results to range from zero cents to 5 cents per share.

  • Revenue rose 15.9% to $148.55 million from a year ago; analysts expected $146.38 million.

  • Xometry Inc's reported EPS for the quarter was a loss of 20 cents​.

  • The company reported a quarterly loss of $9.89 million.

  • Xometry Inc shares had fallen by 26.6% this quarter.

FORECAST CHANGES

  • The mean earnings estimate of analysts had risen by about 9.6% in the last three months.​

  • In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 2 "hold" and 1 "sell" or "strong sell."

  • The average consensus recommendation for the it services & consulting peer group is also "buy"

Wall Street's median 12-month price target for Xometry Inc is $38.50

This summary was machine generated from LSEG data February 25 at 02:32 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Dec. 31 2024

0.03

0.06

Beat

Sep. 30 2024

-0.02

0.02

Beat

Jun. 30 2024

-0.12

-0.01

Beat

Mar. 31 2024

-0.13

-0.12

Beat

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10